NDC 0575-6200

Proglycem

Diazoxide

Proglycem is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Diazoxide.

• Product ID: 0575-6200_47b69092-a26a-4a67-b068-262b240a8a9a
• NDC: 0575-6200
• Product Type: Human Prescription Drug
• Proprietary Name: Proglycem
• Generic Name: Diazoxide
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 1990-09-30
• Marketing Category: NDA / NDA
• Application Number: NDA017453
• Labeler Name: Teva Pharmaceuticals USA, Inc.
• Substance Name: DIAZOXIDE
• Active Ingredient Strength: 50 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2024-12-31

Packaging

NDC 0575-6200-30

1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) > 30 mL in 1 BOTTLE, DROPPER

• Marketing Start Date: 1990-09-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0575-6200-30 [00575620030]

Proglycem SUSPENSION

• Marketing Category: NDA
• Application Number: NDA017453
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 1990-09-30

Drug Details

Active Ingredients

Ingredient	Strength
DIAZOXIDE	50 mg/mL

OpenFDA Data

• SPL SET ID: b16c7832-2fd9-49af-b923-1dc0d91fd6e2
• Manufacturer:
  • Teva Pharmaceuticals USA, Inc.
• UNII:
  • O5CB12L4FN
• RxNorm Concept Unique ID - RxCUI:
  • 207634
  • 197593

NDC Crossover Matching brand name "Proglycem" or generic name "Diazoxide"

NDC	Brand Name	Generic Name
0575-6200	Proglycem	diazoxide
0254-1010	Diazoxide	Diazoxide
13517-100	Diazoxide	diazoxide